Amber Lifesciences Delivers Quality Fenofibrate API

Choline Fenofibrate API is a lipid-lowering active pharmaceutical ingredient widely used in the formulation of medicines for managing high cholesterol and triglyceride levels. The API offers improved bioavailability compared to conventional fenofibrate formulations, making it a preferred choice for pharmaceutical manufacturers. As cardiovascular diseases continue to increase worldwide, demand for Choline Fenofibrate API is growing across both developed and emerging healthcare markets.

Choline Fenofibrate API – Key Information

Product Name: Choline Fenofibrate API
Generic Name: Choline Fenofibrate
CAS Number: 856676-23-8
Molecular Formula: C₂₂H₂₈ClNO₅
Molecular Weight: 421.92 g/mol

Pharmacological Class

  • Fibric Acid Derivative – Belongs to the fibrate class of lipid-modifying agents.
  • Antihyperlipidemic Agent – Used to reduce elevated triglycerides and improve lipid profiles.
  • Cardiovascular Health API – Supports the management of dyslipidemia and cardiovascular risk factors.
  • PPAR-α Agonist – Activates peroxisome proliferator-activated receptor alpha (PPAR-α) to enhance lipid metabolism.
  • Active Pharmaceutical Ingredient (API) – Widely used in the manufacturing of tablets and capsules for cholesterol and triglyceride management.

United States Leads Choline Fenofibrate Demand

The United States represents one of the largest markets for Choline Fenofibrate API due to the high prevalence of dyslipidemia, obesity, and cardiovascular disorders. Strong healthcare infrastructure, extensive prescription usage, and continuous demand for generic medicines contribute to market growth. Europe, particularly Germany, France, and Italy, also demonstrates significant consumption, while emerging markets in Asia-Pacific are witnessing rapid expansion.

Growing Applications Drive Market Expansion Worldwide

Choline Fenofibrate API is primarily used in pharmaceutical formulations for treating hypertriglyceridemia and mixed dyslipidemia. Increasing awareness of cardiovascular health and preventive healthcare measures has boosted prescription rates globally. Pharmaceutical companies are actively developing generic and branded formulations, creating consistent demand for high-quality API suppliers capable of meeting international standards.

Regulatory Compliance Essential For Market Entry

Manufacturers supplying Choline Fenofibrate API must comply with stringent regulatory requirements established by authorities such as the U.S. FDA, EMA, CDSCO, and other regional agencies. Regulatory approvals require comprehensive documentation, quality validation, stability studies, and adherence to Good Manufacturing Practices (GMP). Compliance with these regulations ensures product safety, efficacy, and market acceptance.

Registration Process For International Pharmaceutical Markets

Import and registration procedures vary by country but generally require a Drug Master File (DMF), Certificate of Analysis (COA), GMP certification, and product specifications. Pharmaceutical importers must submit regulatory dossiers to local health authorities for evaluation and approval. Partnering with experienced API manufacturers can significantly streamline registration processes and accelerate market access.

Emerging Regions Offer Significant Growth Opportunities

Asia-Pacific, Latin America, the Middle East, and Africa present attractive growth opportunities for Choline Fenofibrate API suppliers. Rising healthcare expenditure, growing generic drug manufacturing, and increasing cardiovascular disease prevalence support market expansion. Countries such as India, Brazil, Mexico, Saudi Arabia, and South Africa are expected to witness strong demand over the coming years.

Amber Lifesciences Delivers Trusted API Solutions

Amber Lifesciences is committed to supplying high-quality pharmaceutical APIs that meet international regulatory and quality standards. With advanced manufacturing capabilities, robust quality control systems, and a customer-focused approach, the company supports pharmaceutical manufacturers across global markets. Amber Lifesciences emphasizes reliability, regulatory compliance, and timely delivery to help clients achieve successful product commercialization.

Frequently Asked Questions About Choline Fenofibrate

Q1. Which region has the highest demand for Choline Fenofibrate API?
The United States currently represents one of the largest and most established markets.

Q2. What is Choline Fenofibrate API used for?
It is used in formulations designed to manage elevated cholesterol and triglyceride levels.

Q3. What documents are required for API registration?
Common requirements include DMF, GMP certificates, COA, stability data, and technical dossiers.

Q4. Which emerging markets offer growth potential?
India, Brazil, Mexico, Saudi Arabia, and several African countries show strong growth prospects.

Q5. Why choose Amber Lifesciences for APIs?
Amber Lifesciences offers quality manufacturing, regulatory support, international compliance, and dependable supply chain management.